Literature DB >> 15032714

What have genetically engineered mice taught us about ischemic injury?

Dong Liang1, Ted M Dawson, Valina L Dawson.   

Abstract

Stroke, is the third leading cause of death and disability in the Western world. Stroke refers to set of ischemic conditions resulting from the occlusion or hemorrhage of blood vessels supplying the brain. Loss of blood flow to the brain results in neuronal injury due to both oxygen and nutrient deprivation and the activation of injurious signal cascades. Ultimately cerebral ischemia results in death and dysfunction of brain cells, and neurological deficits that reflect the location and size of the compromised brain area. Injury due to ischemic stroke occurs by a highly choreographed series of complex spatial and temporal events that evolve over hours to days. These events involve complex interactions between fundamental cell injury mechanisms including excitotoxicity and ionic imbalance, oxidative and nitrosative stress, apoptotic-like cell death and inflammatory responses. Genetically engineered mice have been valuable tools to probe putative mechanisms of neuronal death and uncover potential strategies that might render neurons resistant to ischemic injury. Findings from experimental stroke studies in genetically engineered animals are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032714     DOI: 10.2174/1566524043479194

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  7 in total

1.  Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia.

Authors:  Shengxiang Zhang; Jamie Boyd; Kerry Delaney; Timothy H Murphy
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 2.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

Review 3.  Experimental models, neurovascular mechanisms and translational issues in stroke research.

Authors:  E H Lo
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

4.  Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia.

Authors:  Jamie N Mayo; Richard S Beard; Tulin O Price; Cheng-Hung Chen; Michelle A Erickson; Nuran Ercal; William A Banks; Shawn E Bearden
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-21       Impact factor: 6.200

5.  Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo.

Authors:  Chikako Harada; Kazuaki Nakamura; Kazuhiko Namekata; Akinori Okumura; Yoshinori Mitamura; Yoko Iizuka; Kenji Kashiwagi; Kazuhiko Yoshida; Shigeaki Ohno; Atsushi Matsuzawa; Kohichi Tanaka; Hidenori Ichijo; Takayuki Harada
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

6.  Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.

Authors:  Ambreena Siddiq; Issam A Ayoub; Juan C Chavez; Leila Aminova; Sapan Shah; Joseph C LaManna; Stephanie M Patton; James R Connor; Robert A Cherny; Irene Volitakis; Ashley I Bush; Ingrid Langsetmo; Todd Seeley; Volkmar Gunzler; Rajiv R Ratan
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

7.  Identification through high-throughput screening of 4'-methoxyflavone and 3',4'-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos.

Authors:  A A Fatokun; J O Liu; V L Dawson; T M Dawson
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.